Fissure-in-ano is a common condition causing considerable morbidity in a ge
nerally young and otherwise healthy population. The use of pharmacological
agents in the treatment of this condition, so-called chemical sphincterotom
y, is increasing. Topical glyceryl trinitrate is now widely accepted as fir
st-line therapy, and recent studies indicate that alternative drugs may be
similarly efficacious but with fewer side effects. Botulinum toxin A inject
ion has also been shown to be effective treatment but is more invasive, and
its precise role in the management of fissure-in-ano remains uncertain. Tr
aditional surgical treatments are associated with a risk for impaired anal
continence but remain a valuable option where fissures either persist despi
te pharmacological therapy or repeatedly recur. Where anal pressures are no
t elevated in such patients, however, treatment with anal advancement flaps
should be considered.